Testing effectiveness (Phase 2)Study completedNCT02026401
What this trial is testing
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
Who this might be right for
Primary Biliary Cirrhosis
NGM Biopharmaceuticals, Inc 45
Showing 20 of 0 results